|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Deferred offering costs-non-current asset | |||
| Cash | |||
| Prepaid expense and insurance | |||
| Total Current Assets | |||
| Deferred offering costs | |||
| Long-term prepaid insurance | |||
| Cash held in Trust Account | |||
| TOTAL ASSETS | |||
| Current Liabilities | |||
| Accrued expenses | |||
| Accrued offering costs | |||
| Accounts payable and accrued expenses | |||
| Offering costs payable | |||
| Short-term loan | |||
| Promissory note - related party | |||
| Related Party | |||
| Total promissory note - related party | |||
| Total Current Liabilities | |||
| Deferred underwriting fee payable | |||
| Total Liabilities | |||
| Commitments and Contingencies (Note 5) | |||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,850,000 and no shares at a redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders’ Deficit | |||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026 and December 31, 2025, respectively | |||
| Common stock value | |||
| Class A Ordinary Shares | |||
| Class B Ordinary Shares | |||
| Stock subscription receivable from Sponsor | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...
